Previous studies have suggested that vitamin K deficiency, a typical complication in patients with chronic cholestasis, may also impact PIVKA-II and AFP levels, as vitamin levels were negatively correlated with serum TB levels.[31] This suggests that levels closer to normal for GGT and TB in hepatopath may influence the diagnostic efficacy of PIVKA-II and AFP for liver cancer. Here, AFP is linked to liver cancer.